E-DRUG: 1999 US International Response to HIV/AIDS (cont)
---------------------------------------------------------
In New Zealand, Bristol Myers Squibb is currently selling ddI
(Didanosine, a drug developed and patented by the NIH) at a 30% higher
price than it is sold in the United States, despite the fact that the
New Zealand per capita income in roughly the half of what it is in the
US.
Is this particular discreopancy not perhaps explained by the lack of demand
for the drug in New Zealand? I believe there are less than 40 AIDs victims
in the entire country.
Steve Toovey
Email: toovey@iafrica.com
[can E-druggers please add a signature to their messages with their
professional affiliation, snailmail, tel, fax and email?
Thx, Wilbert Bannenberg. co-moderator]
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.